aspafilioside B

steroidal saponin from Asparagus filicinus; used for treatment of bronchitis, pneumonitis & cough; structure given in first source

Also Known As:

sarsasapogenin-3-O-beta-D-xylopyranosyl-(1-4)-(alpha-L-arabinopyranosyl-(1-6))-beta-D-glucopyranoside; beta-D-Glucopyranoside, (3 beta,5beta,25S)-spirostan-3-yl O-alpha-L-arabinopyranosyl-(1-6)-O-(beta-D-xylopyranosyl-(1-4))-

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Chen, Rui-Ni: 1 article (05/2016)
2.	Dai, Qin-Sheng: 1 article (05/2016)
3.	Guo, Qing-Long: 1 article (05/2016)
4.	Hu, Gang: 1 article (05/2016)
5.	Hu, Jin-Hua: 1 article (05/2016)
6.	Huang, Xue-Feng: 1 article (05/2016)
7.	Liu, Wei: 1 article (05/2016)
8.	Ning, Rui: 1 article (05/2016)
9.	Wang, Hao: 1 article (05/2016)
10.	Wang, Yu-Wen: 1 article (05/2016)

Related Diseases

1.	Neoplasms (Cancer) 05/01/2016 - "Finally, in vivo, aspafilioside B suppressed tumor growth in mouse xenograft models, and the mechanism was the same as in vitro study. "
2.	Hepatocellular Carcinoma (Hepatoma) 05/01/2016 - "Aspafilioside B induces G2/M cell cycle arrest and apoptosis by up-regulating H-Ras and N-Ras via ERK and p38 MAPK signaling pathways in human hepatoma HepG2 cells."

Related Drugs and Biologics

1.	p38 Mitogen-Activated Protein Kinases